Cargando…

Bilateral jaw dislocation following botulinim toxin type A treatment for chronic migraine

Detalles Bibliográficos
Autores principales:	Forbes, RB, Devenney, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620195/ http://dx.doi.org/10.1186/1129-2377-1-S14-P211

Ejemplares similares

Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
por: Ahmed, F, et al.
Publicado: (2013)

Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

P042. Mechanism of action and clinical evidence of botulinum toxin in chronic migraine
por: Franco, Giovanni, et al.
Publicado: (2015)

Major life events, stress appraisal, and migraine: results of the American Migraine Prevalence and Prevention (AMPP) study
por: Manack, AN, et al.
Publicado: (2013)

Tension type headache is dead; long live chronic migraine!
por: Elrington, GE
Publicado: (2013)

Adding acute treatments for patients on triptans: Results of the American Migraine Prevalence & Prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

History of a Case of Dislocation of the Lower Jaw
por: Forbes, John
Publicado: (1817)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

Knowledge, attitudes and clinical practice regarding behavioral treatments and psychological issues in migraine: a survey of AHS members
por: Buse, DC, et al.
Publicado: (2013)

Multimodal evoked potentials in chronic migraine
por: Coppola, G, et al.
Publicado: (2013)

P005. Efficacy Type-A Botulinum toxin treatment in a multidisciplinary setting for chronic headache
por: Vescio, Giuseppe, et al.
Publicado: (2015)

Migraine headache is present in the aura phase – a prospective study
por: Hansen, JM, et al.
Publicado: (2013)

Effectiveness of integrated yoga therapy in treatment of chronic migraine: randomized controlled trial
por: Sharma, N, et al.
Publicado: (2013)

Characterization of a novel model for chronic migraine
por: Pradhan, A, et al.
Publicado: (2013)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

P010. OnabotulinumtoxinA for treatment of chronic migraine: results after 1 year of treatment
por: Rossi, Eleonora, et al.
Publicado: (2015)

P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients
por: Iannacchero, Rosario, et al.
Publicado: (2015)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

Pressure pain thresholds in chronic migraine associated with hypertension
por: Grosu, O, et al.
Publicado: (2013)

Chronic migraine is not associated with cerebellar infarct-like lesions
por: Meilan, A, et al.
Publicado: (2013)

Pericranial muscle tenderness in a population based sample of chronic tension-type headache. The Akershus study of chronic headache
por: Aaseth, K, et al.
Publicado: (2013)

High prevalence of right to left shunt in women with chronic migraine
por: Larrosa, D, et al.
Publicado: (2013)

BDNF gene polymorphysm RS2049046 in episodic and chronic migraine
por: Azimova, Y, et al.
Publicado: (2013)

Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
por: Rothrock, JF, et al.
Publicado: (2013)

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
por: Silberstein, S, et al.
Publicado: (2013)

Dislocations—Fractures of the Jaw
por: Prideaux, H. S.
Publicado: (1892)

Dislocation of the Lower Jaw
Publicado: (1851)

P025. Two-year follow-up with OnabotulinumtoxinA for chronic migraine: a real life evaluation of 113 patients
por: Santoro, Antonio, et al.
Publicado: (2015)

Neurocognitive function declines are reversible following migraine headache in college students
por: Moore, MT, et al.
Publicado: (2013)

Temperament and character profiles of patients with chronic migraine and medication-overuse headache
por: Watanabe, Y, et al.
Publicado: (2013)

Ornithine in chronic migraine therapy and allodynia pattern: comparison with dopaminergic activation
por: Nicolodi, M, et al.
Publicado: (2013)

The differences in trigeminal system functional state in chronic and frequent migraine patients
por: Pavlic, G, et al.
Publicado: (2013)

P008. Alexithymia and chronic migraine with medication overuse: what relationship?
por: Bottiroli, Sara, et al.
Publicado: (2015)

O048. Chronic migraine, cluster headache or both? The suggestion of botulinum toxin
por: Ripa, Patrizia, et al.
Publicado: (2015)

Hemodynamic instability following bilateral carotid endarterectomy
por: Govindarajan, R, et al.
Publicado: (2005)

P043. Hyperechogenicity of the periaqueductal gray in chronic migraine and episodic migraine as a potential marker of progressive dysfunction: preliminary results with transcranial sonography
por: Guaschino, Elena, et al.
Publicado: (2015)

Survey of the differences between Migraine and MOH pre-existing migraine
por: Igarashi, H
Publicado: (2013)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
por: Aurora, SK, et al.
Publicado: (2013)

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
por: Diener, HC, et al.
Publicado: (2013)

P054. Chronic migraine and onabotulinumtoxinA: results from clinical practice
por: Paolucci, Matteo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c2cndd1io005ar8tmrfbqpnbts